Touchlight and 20Med partner on vaccine platform
Link-up has already delivered data showing the promise of nanoparticle-formulated doggybone DNA
Read Moreby John Pinching | Apr 19, 2023 | News | 0
Link-up has already delivered data showing the promise of nanoparticle-formulated doggybone DNA
Read Moreby John Pinching | Dec 7, 2022 | News | 0
Partnership aims to progress personalised cancer therapy by incorporating doggybone DNA
Read Moreby John Pinching | Nov 29, 2022 | News | 0
Bill & Melinda Gates Foundation grant will boost potential of nanoparticle-formulated doggybone DNA
Read Moreby John Pinching | Jul 6, 2022 | News | 0
Deal involves the manufacturing of mRNA-based vaccines, therapeutics and gene therapies
Read Moreby Lucy Parsons | Mar 11, 2021 | News | 0
Proceeds will be used to ‘more than triple’ UK biotech’s manufacturing capabilities
Read More




PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
